ESPAX | VISVX | ESPAX / VISVX | |
Total Expense Ratio | 1.41 | 0.19 | 742% |
Annual Report Gross Expense Ratio | 1.41 | 0.19 | 742% |
Fund Existence | 32 years | 27 years | - |
Gain YTD | -2.104 | 6.095 | -35% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.15B | 59.2B | 7% |
Annual Yield % from dividends | 0.87 | 1.86 | 47% |
Returns for 1 year | -8.80 | 7.05 | -125% |
Returns for 3 years | 9.04 | 36.11 | 25% |
Returns for 5 years | 35.60 | 86.15 | 41% |
Returns for 10 years | 49.18 | 117.06 | 42% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MLAAX | 10.94 | 0.12 | +1.11% |
NYLI Winslow Large Cap Growth Class A | |||
IJPIX | 12.30 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity S | |||
TQVAX | 19.02 | N/A | N/A |
T. Rowe Price Integrated US LCV Eq Adv | |||
OMCIX | 53.07 | N/A | N/A |
Oberweis Micro Cap Institutional | |||
BIALX | 29.99 | N/A | N/A |
Brown Advisory Global Leaders Investor |